Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.

Christine Au-Yeung is a partner-elect in the San Francisco and Palo Alto offices of Wilson Sonsini Goodrich & Rosati, where she specializes in trademark, copyright, and advertising law. She counsels clients on all aspects of brand protection in the U.S. and throughout the world, including clearance and selection of trademarks, prosecution of trademark applications, licensing, and the resolution of trademark infringement and domain name disputes. She also advises clients on advertising issues, including TCPA compliance related to marketing calls and texts as well as strategies on promotions such as sweepstakes and contests.

Hin Au is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Hin provides IP strategy and counseling services to clients in a wide range of technical fields, including MedTech, digital health, biotech, medical/diagnostic devices, software, robotics, autonomous vehicle technologies, and clean energy. He has assisted many clients with building their patent portfolios and securing key strategic patents. Hin has hands-on engineering industry experience, having previously worked as an R&D engineer for six years at large U.S. semiconductor corporations. A native of Singapore, Hin is also fluent in Mandarin and Cantonese.

Megan represents technology and life sciences clients in corporate transactional matters.

Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.

Matt is primary outside IP counsel to more than 50 life sciences companies in Southern California.

Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.

Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.

James advises life sciences and tech companies on a wide variety of matters and has extensive experience working with venture capital firms and other investors in private equity and debt financings.

Alex focuses on representing clients in the biotechnology, pharmaceutical, medical device, diagnostic, and digital health industries.

Michael Klippert is a partner in Wilson Sonsini Goodrich & Rosati's employee benefits and compensation practice. Michael represents a wide range of public and private companies with respect to compensation and benefit matters, particularly within the technology, medical device manufacturing, and life science sectors.

Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than a decade dedicated to healthcare law, Andrea exclusively represents digital health and healthcare IT clients, from emerging companies to established industry players, investors, and healthcare systems. Andrea guides her clients through the patchwork of federal and state laws that apply to digital health companies, addressing issues such as corporate practice of medicine, Stark Law compliance, Anti-Kickback Statute considerations, fee splitting, billing Medicare and Medicaid, contracting with commercial payors, value-based care arrangements, artificial intelligence, remote patient monitoring, online prescribing, scope of practice, and licensing requirements.

Maneesha Mithal is a partner in the Washington, D.C., office of Wilson Sonsini and co-chair of the firm’s privacy and cybersecurity practice. Maneesha advises clients on privacy, cybersecurity, and consumer protection matters and represents companies in regulatory investigations. She is also one of the founding members of Wilson Sonsini’s AI group.

Philip focuses primarily on the representation of medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies in corporate governance, IPO, M&A, public company reporting, and private equity and debt financing matters.

Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.

Maya focuses on strategic patent counseling for healthcare and other technology-driven companies.

Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.